Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

A

AKTX

Akari Therapeutics Plc ADR

7.39

Aug 04 • 9:44 AM ET +0.03 (0.48%)

Healthcare Biotechnology USA Nano NASD

Peers: IKT NBP NERV NVCT ALXO BCYC CGEN FATE FHTX CDXS

Scroll to Statements

Index	-
Market Cap	8.43M
Enterprise Value	6.33M
Income	-28.00M
Sales	0.00M
Book/sh	12.56
Cash/sh	2.48
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	6
IPO	May 07, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.59
P/C	2.98
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.27
Current Ratio	0.27
Debt/Eq	0.05
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-18.86
EPS next Y	-2.56
EPS next Q	-1.04
EPS this Y	61.27%
EPS next Y	68.04%
EPS next 5Y	44.90%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-75.83%
Sales Q/Q	-
Earnings	May 14
EPS/Sales Surpr.	-632.33% -

Insider Own	0.40%
Insider Trans	0.00%
Inst Own	14.02%
Inst Trans	34.85%
ROA	-66.00%
ROE	-155.01%
ROIC	-194.71%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-28.26%
SMA50	-39.78%
SMA200	-38.91%
Trades

Shs Outstand	1.14M
Shs Float	1.14M
Short Float	1.44%
Short Ratio	0.02
Short Interest	0.02M
52W High	49.60 -85.09%
52W Low	3.02 145.27%
Volatility	7.09% 14.60%
ATR (14)	1.32
RSI (14)	33.89
Beta	1.39
Rel Volume	0.00
Avg Volume	783.42K
Volume	290

Perf Week	-12.28%
Perf Month	-32.16%
Perf Quarter	23.46%
Perf Half Y	-21.99%
Perf YTD	-36.03%
Perf Year	-82.05%
Perf 3Y	-96.51%
Perf 5Y	-99.43%
Perf 10Y	-99.91%
Recom	1.00
Target Price	30.00
Prev Close	7.36
Price	7.39
Change	0.48%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)